Сравнение методов
Просматривайте выбранные методы рядом; строки с различиями подсвечены.
| Опросник Кларка для оценки осведомленности о гипогликемии× | ThyPRO: Шкала оценки качества жизни пациентов с заболеваниями щитовидной железы× | |
|---|---|---|
| Область | Эндокринология | Эндокринология |
| Семейство | Process / pipeline | Process / pipeline |
| Год появления≠ | 1995 | 2009 |
| Автор метода≠ | William L. Clarke, Don J. Cox, Lois A. Gonder-Frederick | Torquil Watt, Jens Bjørner, Marianne Groenvold |
| Тип | Patient self-report questionnaire | Patient self-report questionnaire |
| Основополагающий источник≠ | Clarke, W. L., Cox, D. J., Gonder-Frederick, L. A., Julian, D., Schlundt, D., & Polonsky, W. (1995). Reduced awareness of hypoglycemia in adults with IDDM: A prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care, 18(6), 517-522. DOI ↗ | Watt, T., Bjorner, J. B., Groenvold, M., et al. (2009). Establishing construct validity for the thyroid-related patient reported outcomes (ThyPRO): An initial examination. J Clin Endocrinol Metab, 94(9), 3572-3580. link ↗ |
| Другие названия≠ | HAQ, Clarke HAQ, Hypoglycemia Awareness Scale | ThyPRO-85, ThyPRO-39 |
| Связанные | 3 | 3 |
| Сводка≠ | The Clarke Hypoglycemia Awareness Questionnaire is an 8-item instrument designed to identify patients with impaired hypoglycemia awareness—a condition in which diabetic patients fail to perceive early warning symptoms of low blood glucose, substantially increasing their risk of severe hypoglycemia. Developed by Clarke and colleagues in 1995, it is the most widely used screening tool for this dangerous complication in type 1 diabetes and in insulin-treated type 2 diabetes populations. | ThyPRO is a comprehensive patient-reported outcome measure assessing the quality of life impact of thyroid disease and its treatment across 13 dimensions. Developed by Watt and colleagues in 2009, it is the most extensively validated thyroid-specific instrument, covering both physical and psychological domains relevant to patients with hyperthyroidism, hypothyroidism, and thyroid cancer. |
| ScholarGateНабор данных ↗ |
|
|